BR9500296A - Solução aquosa de lipossomas e preparação de lipossomas liofilizados - Google Patents

Solução aquosa de lipossomas e preparação de lipossomas liofilizados

Info

Publication number
BR9500296A
BR9500296A BR9500296A BR9500296A BR9500296A BR 9500296 A BR9500296 A BR 9500296A BR 9500296 A BR9500296 A BR 9500296A BR 9500296 A BR9500296 A BR 9500296A BR 9500296 A BR9500296 A BR 9500296A
Authority
BR
Brazil
Prior art keywords
liposomes
preparation
aqueous solution
lyophilized
lyophilized liposomes
Prior art date
Application number
BR9500296A
Other languages
English (en)
Inventor
Michel Fernex
Hans Steffen
Andreas Supersaxo
Frank-Peter Theil
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9500296A publication Critical patent/BR9500296A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR9500296A 1994-01-25 1995-01-24 Solução aquosa de lipossomas e preparação de lipossomas liofilizados BR9500296A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH21394 1994-01-25

Publications (1)

Publication Number Publication Date
BR9500296A true BR9500296A (pt) 1995-10-17

Family

ID=4181848

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9500296A BR9500296A (pt) 1994-01-25 1995-01-24 Solução aquosa de lipossomas e preparação de lipossomas liofilizados

Country Status (10)

Country Link
EP (1) EP0664117A1 (pt)
JP (1) JPH07206713A (pt)
KR (1) KR950031041A (pt)
CN (1) CN1111125A (pt)
AU (1) AU699142B2 (pt)
BR (1) BR9500296A (pt)
CA (1) CA2140701A1 (pt)
NZ (1) NZ270362A (pt)
RU (1) RU95101041A (pt)
ZA (1) ZA95404B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
CN102048740B (zh) * 2010-12-02 2012-06-13 郝志艳 头孢曲松钠他唑巴坦钠药物组合物脂质体注射剂
CA2848012A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN102973568B (zh) * 2012-12-10 2014-08-27 江苏开元医药化工有限公司 头孢曲松钠舒巴坦钠的药物组合物脂质体的制备方法
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN112791074B (zh) * 2021-03-17 2022-10-04 中山大学 鱼腥草素和/或新鱼腥草素钠在制备ndm-1抑制剂中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
EP0479582A1 (en) * 1990-10-03 1992-04-08 Alexander Karl Friedrich Wilhelm Overweg Restorative periodontal technique

Also Published As

Publication number Publication date
NZ270362A (en) 1996-10-28
ZA95404B (en) 1995-07-25
CA2140701A1 (en) 1995-07-26
EP0664117A1 (de) 1995-07-26
RU95101041A (ru) 1997-02-27
CN1111125A (zh) 1995-11-08
AU699142B2 (en) 1998-11-26
JPH07206713A (ja) 1995-08-08
KR950031041A (ko) 1995-12-18
AU1029895A (en) 1995-08-03

Similar Documents

Publication Publication Date Title
EE03976B1 (et) Erütromütsiinid ja nende valmistamise meetod
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
PL330903A1 (en) Aqueous preparations of peptides
FI973750A0 (fi) 2-metyylitienobentsodiatsepiinin valmistus ja kiteiset muodot
MA23838A1 (fr) Solution aqueuse d'interferon x
PL318132A1 (en) Aqueous preparations of risperidone
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
DE69623914T2 (de) Äusserliches hautpräparat
IL122215A (en) Dolastatin derivatives as antineoplastics and their preparation
BR9500296A (pt) Solução aquosa de lipossomas e preparação de lipossomas liofilizados
PL342362A1 (en) Water-containing preparations of parasticides applicable onto skin
FI965204A0 (fi) Bromelaiinin lääkekäyttö
BR9504463A (pt) Processo para preparaçao de lipossomas de quetoprofeno e preparaçoes farmacêuticas
DE69934889D1 (de) Herstellung und reinigung von diboranen
FI964193A (fi) Puriinien valmistaminen
BR9506020A (pt) Composição aquosa e processo de preparaçao da mesma
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
BR9106742A (pt) Preparacao de pentafluoretos de niobio e de tantalo anidros
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
FI963263A (fi) Bromelaiinin lääkinnällinen käyttö
DE59504988D1 (de) Niedrigviskose wässrige konzentrate von betaintensiden
ITMI932343A1 (it) Procedimento per l'isolamento e la purificazione di mevinolina
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
FI972791A (fi) Orgaanisten happojen ja aminohappojen valmistus

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]